KASHIWA Nobuyuki
| Qualification | Attorney at Law, Patent Attorney |
|---|---|
| Departments | Litigations, Trademarks, Chinese Market |
| Specialization | IP infringement litigation, Appeals, invalidation trials, oppositions, prosecutions, contracts, application proceedings, pharmaceutical procedures, others |
Background
After graduating from the University of Tokyo and becoming licensed as a pharmacist in 2002, Nobuyuki Kashiwa obtained his master’s degree in Pharmaceutical Sciences from the University of Tokyo Graduate School in 2004. He was registered as an attorney at law in 2008, and as a patent attorney in 2010.
After joining Kyowa in 2008, he has handled numerous contentious matters, primarily representing Japanese and foreign pharmaceutical, chemical, food, and consumer goods companies in patent infringement litigation, preliminary injunction proceedings, appeals against JPO trial decisions, warning-letter negotiations, invalidation trials, hantei advisory opinion proceedings, and oppositions. He has extensive experience in contract-related matters, legal opinions, various legal consultations, and intellectual property matters involving trademarks, designs, copyrights, and unfair competition, as well as general civil and corporate legal matters.
In addition to his legal practice, since 2015 he is a member of the Editorial Board of AIPPI Japan’s periodical. Starting in 2026, he is serving as an instructor in the Japan Patent Attorneys Association’s litigation representative specialization training program for patent attorneys seeking to qualify as infringement litigation representatives.
Articles
- Therapeutic Antibody Invention Claimed by Functional Limitations: Intellectual Property High Court Ruled the Claim Did Not Fulfill the Support Requirement Judgment of the Intellectual Property High Court, Fourth Division on January 26, 2023 (2021 (Gyo-Ke) 10093, 10094; “Antibody Preparation Case”) - AIPPI Japan Journal International Edition (Vol. 49 No.2 2024)
- Intellectual Property High Court Judgement regarding the Description Requirement and Correction Requirement for a Use Limitation in Pharmaceutical Inventions (2020 (Gyo-Ke) 10135; "Pregabalin Case" - AIPPI Japan Journal International Edition (Vol. 48 No.2 2023)
- The Equol-Containing Extract: A case in which the Intellectual Property High Court Recognized the Presumption of Article 104 of the Patent Act and Ruled in Favor of the Patentee - JIPA INTELLECTUAL PROPERTY MANAGEMENT (Vol. 73 No. 3 2023)
- Calculation Methods Regarding Damages Based on Article 102, Paragraphs 2 and 3 of the Patent Act (Grand Panel Decision of Intellectual Property High Court Dated June 7, 2019 - AIPPI Japan Journal (Vol. 65 No. 3 2020)
- Intellectual Property in Electronics and Software - A Global Guide to Rights and Their Applications Second Edition - Globe Law and Business (2019)
- The Supreme Court Decision Regarding the Requirements for Infringement under the Doctrine of Equivalents - AIPPI Japan Journal International Edition (Vol. 43 No.1 2018)
- The Intellectual Property High Court Grand Panel Decision on the Requirements for Infringement under the Doctrine of Equivalents - AIPPI Japan Journal International Edition (Vol. 42 No.1 2017)
- Consideration Regarding Experimental Data in Datamining Patentability of Numerically Limited Inventions - JIPA INTELLECTUAL PROPERTY MANAGEMENT (Vol. 65 No. 8 2015)
- Unpredictable Remarkable Effects in Determining Inventive Step (Supreme Court Decision Dated August 27, 2019) - SHINNIPPON-HOKI “Practical Methods for Preventing Troubles Relating to Intellectual Property”
- Clarity and the Diaper Decision - Managing Intellectual Property SURVEY 2011